7 XNAS Volume
XNAS 19 Mar, 2025 9:38 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| T. Proehl Gerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Robyn M Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Declan Doogan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Davidson Michael Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Rich Stuart | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Giordano T. Christopher | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 1,250,000 | 1,250,000 | - | - | Stock Option (right to buy) | |
| Almenoff S. June | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Gerald T. Proehl | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 1,666 | 1,667 (0%) | 0% | - | Common Stock | |
| Gerald T. Proehl | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 16,660 | 16,660 | - | - | Warrant | |
| Gerald T. Proehl | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 31,654 | 31,654 | - | - | Pre-Funded Warrant | |
| Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 2,500 | 2,881 (0%) | 0% | - | Common Stock | |
| Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 47,500 | 47,500 | - | - | Pre-Funded Warrant | |
| Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 25,000 | 25,000 | - | - | Warrant | |
| Stuart Rich | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 119 | 119 | - | - | Stock Option (right to buy) | |
| Christopher T. Giordano | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 437 | 437 | - | - | Stock Option (right to buy) | |
| Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 1,909,585 (28%) | 28% | 0 | Common Stock | |
| Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 0 (0%) | 28% | 0 | Common stock | |
| Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 1,909,585 (28%) | 28% | 0 | Common stock | |
| Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 2,333,932 (34%) | 28% | 0 | Common Stock | |
| Anthony A. DiTonno | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Declan Doogan | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2021 | 567,871 | 2,502,129 (37%) | 8% | 0 | Common Stock | |
| Stuart Rich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Stuart Rich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,581 | 3,581 | - | - | Series B Preferred Stock | |
| Stuart Rich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 662,517 | 662,517 (9%) | 9% | - | Common Stock | |
| Anthony A. DiTonno | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 90,000 | 90,000 | - | - | Stock option (right to buy) | |
| Michael B. Jebsen | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| Blanck R Ronald | Director | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 18 May 2020 | 5,000 | 6,062 (0%) | 0% | 1.0 | 4,774 | Common Stock |
| Gerald T. Proehl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 500 | 500 | - | - | Stock Option (right to buy) | |
| James Mitchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Blanck R Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Anthony A. DiTonno | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2020 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Michael B. Jebsen | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2020 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Chris A. Rallis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2019 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Chris A. Rallis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2019 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 6.25 per share. | 07 Aug 2018 | 5,720 | 34,680 (2%) | 0% | 6.3 | 35,750 | common stock |
| Gerald T. Proehl | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2018 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Anthony A. DiTonno | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2018 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Anthony A. DiTonno | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2018 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| James Mitchum | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2018 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Blanck R Ronald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2018 | 500 | 500 | - | - | Stock Option (right to buy) | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 5.42 per share. | 05 Apr 2018 | 6,425 | 12,310 (0%) | 0% | 5.4 | 34,824 | common stock |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.43 per share. | 29 Dec 2017 | 98 | 68,264 (0%) | 0% | 0.4 | 42 | common stock |
| Blanck R Ronald | None | Purchase of securities on an exchange or from another person at price $ 0.44 per share. | 18 Dec 2017 | 6,475 | 20,099 (0%) | 0% | 0.4 | 2,881 | Common Stock |
| Blanck R Ronald | None | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 18 Dec 2017 | 6,475 | 13,624 (0%) | 0% | 0.5 | 3,006 | Common Stock |
| Blanck R Ronald | None | Sale of securities on an exchange or to another person at price $ 0.39 per share. | 14 Nov 2017 | 12,950 | 7,149 (0%) | 0% | 0.4 | 5,051 | Common Stock |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.65 per share. | 31 Jul 2017 | 54 | 68,146 (0%) | 0% | 0.6 | 35 | common stock |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.54 per share. | 18 Apr 2017 | 56 | 68,200 (0%) | 0% | 0.5 | 30 | common stock |
| Michael B. Jebsen | Interim CEO, President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| John P. Kelley | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 15 Mar 2017 | 96,999 | 1,282,932 (4%) | 0% | 0.7 | 65,959 | Common Stock |
| John P. Kelley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2017 | 213,420 | 1,379,931 (4%) | 0% | 0 | Common Stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2016 | 49 | 68,256 | - | - | common stock | |
| John P. Kelley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Gerald T. Proehl | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2016 | 14,449 | 29,882 | - | - | Common Stock | |
| Gerald T. Proehl | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2016 | 15,433 | 15,433 | - | - | Common Stock | |
| James Mitchum | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2016 | 7,000 | 26,000 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Sep 2016 | 49 | 68,305 | - | - | common stock | |
| Chris A. Rallis | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2016 | 10,000 | 14,490 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jun 2016 | 55 | 68,354 | - | - | common stock | |
| Blanck R Ronald | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 May 2016 | 3,500 | 20,099 | - | - | common stock | |
| Michael B. Jebsen | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2016 | 430 | 68,409 | - | - | common stock | |
| Blanck R Ronald | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2016 | 1,800 | 16,599 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2016 | 56 | 67,979 | - | - | common stock | |
| James Mitchum | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Feb 2016 | 5,100 | 5,100 | - | - | Common Stock | |
| James Mitchum | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Feb 2016 | 13,900 | 19,000 | - | - | Common Stock | |
| Blanck R Ronald | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2015 | 1,900 | 14,799 | - | - | common stock | |
| Blanck R Ronald | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2015 | 4,700 | 12,899 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2015 | 49 | 68,035 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2015 | 49 | 68,084 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 May 2015 | 55 | 67,703 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2015 | 430 | 68,133 | - | - | common stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2015 | 56 | 67,758 | - | - | Common Stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2014 | 49 | 67,814 | - | - | Common Stock | |
| Michael B. Jebsen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2014 | 50 | 67,863 | - | - | Common Stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2014 | 14,761 | 67,483 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Apr 2014 | 15 | 82,244 | - | - | common stock | |
| Michael B. Jebsen | President and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Mar 2014 | 16 | 82,259 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Feb 2014 | 16 | 50,132 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2014 | 16 | 50,148 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Dec 2013 | 14 | 50,164 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2013 | 14 | 50,178 | - | - | common stock | |
| John P. Kelley | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2013 | 341,711 | 341,711 | - | - | Common Stock | |
| John P. Kelley | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2013 | 8,248 | 8,248 | - | - | Series E Preferred Stock | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2013 | 32,143 | 82,335 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Oct 2013 | 14 | 50,192 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2013 | 79,546 | 50,206 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Sep 2013 | 14 | 1,621 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2013 | 14 | 1,635 | - | - | common stock | |
| Chris A. Rallis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jul 2013 | 5 | 5 | - | - | Series C 8% Convertible Preferred Stock | |
| Chris A. Rallis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jul 2013 | 2,565 | 2,565 | - | - | Common Stock Warrants (right to buy) | |
| Anthony A. DiTonno | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jul 2013 | 5 | 5 | - | - | Series C 8% Convertible Preferred Stock | |
| Anthony A. DiTonno | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jul 2013 | 2,565 | 2,565 | - | - | Common Stock Warrants (right to buy) | |
| Blanck R Ronald | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jul 2013 | 10 | 10 | - | - | Series C 8% Convertible Preferred Stock | |
| Blanck R Ronald | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jul 2013 | 5,129 | 5,129 | - | - | Common Stock Warrants (right to buy) | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2013 | 14 | 1,649 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jun 2013 | 14 | 1,663 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2013 | 8,600 | 33,813 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2013 | 279 | 33,534 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Apr 2013 | 322 | 25,213 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Mar 2013 | 324 | 25,535 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Feb 2013 | 324 | 25,859 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2013 | 324 | 26,183 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2012 | 279 | 26,507 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Nov 2012 | 279 | 26,786 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Oct 2012 | 279 | 27,065 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Aug 2012 | 279 | 27,344 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2012 | 14,938 | 27,623 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2012 | 279 | 12,685 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jun 2012 | 279 | 12,964 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jun 2012 | 279 | 13,243 | - | - | common stock | |
| Chris A. Rallis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2012 | 18,680 | 25,773 | - | - | common stock | |
| Anthony A. DiTonno | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2012 | 25,391 | 35,200 | - | - | Incentive Stock Options | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2012 | 279 | 13,522 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2012 | 8,600 | 13,801 | - | - | common stock | |
| William Chatfield | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2012 | 18,961 | 42,289 | - | - | common stock | |
| Blanck R Ronald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2012 | 18,961 | 43,479 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Apr 2012 | 307 | 5,201 | - | - | common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Mar 2012 | 309 | 5,508 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2012 | 309 | 6,126 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Dec 2011 | 279 | 6,435 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2011 | 279 | 6,714 | - | - | Common stock | |
| Gerald L. Klein | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Oct 2011 | 243 | 13,542 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Oct 2011 | 279 | 6,993 | - | - | Common stock | |
| Gerald L. Klein | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Sep 2011 | 243 | 13,785 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Sep 2011 | 279 | 7,272 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Aug 2011 | 643 | 147,607 | - | - | Common stock | |
| Gerald L. Klein | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Aug 2011 | 243 | 14,028 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Aug 2011 | 279 | 7,551 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Aug 2011 | 279 | 8,388 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Aug 2011 | 279 | 8,109 | - | - | Common stock | |
| Michael B. Jebsen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Aug 2011 | 279 | 7,830 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2011 | 4,470 | 148,250 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2011 | 643 | 153,363 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2011 | 643 | 152,720 | - | - | Common stock | |
| Gerald L. Klein | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2011 | 243 | 14,757 | - | - | Common stock | |
| Gerald L. Klein | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2011 | 243 | 14,514 | - | - | Common stock | |
| Gerald L. Klein | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2011 | 243 | 14,271 | - | - | Common stock | |
| Blanck R Ronald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2011 | 9,538 | 17,028 | - | - | Common stock | |
| Blanck R Ronald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2011 | 7,490 | 7,490 | - | - | Common stock | |
| Gerald L. Klein | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2011 | 40,000 | 40,000 | - | - | EMPLOYEE STOCK OPTION | |
| Gerald L. Klein | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2011 | 7,500 | 15,000 | - | - | COMMON STOCK | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 453 | 35,082 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 35,535 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 453 | 34,601 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 453 | 34,120 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 35,054 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 34,573 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 37,078 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 403 | 35,613 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 37,609 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 403 | 37,206 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 403 | 36,675 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 36,016 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 934 | 36,547 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2010 | 116,800 | 154,006 | - | - | Common stock | |
| Chris J. Stern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Oct 2010 | 403 | 36,144 | - | - | Common stock | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 12,500 | 13,167 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 8,600 | 8,667 | - | - | COMMON STOCK | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2010 | 667 | 667 | - | - | EMPLOYEE STOCK OPTION | |
| Chris J. Stern | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2010 | 570 | 570 | - | - | Common Stock | |
| Chris J. Stern | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2010 | 1,140 | 1,140 | - | - | Common Stock | |
| Chris J. Stern | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2010 | 570 | 570 | - | - | Common Stock | |
| Chris J. Stern | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2010 | 570 | 570 | - | - | Common Stock | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 6,951 | 6,951 | - | - | common stock | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Richard M. Kiral | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 1,334 | 1,334 | - | - | EMPLOYEE STOCK OPTION | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 667 | 667 | - | - | ISO | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 667 | 667 | - | - | ISO | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 667 | 667 | - | - | ISO | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 667 | 667 | - | - | ISO | |
| Michael B. Jebsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2010 | 667 | 667 | - | - | ISO | |
| Richard M. Kiral | Director, President | 30 Apr 2010 | 1,334 | 104,995 | - | - | ISO | ||
| Richard M. Kiral | Director, President | 30 Apr 2010 | 1,334 | 104,995 | - | - | ISO | ||
| Richard M. Kiral | Director, President | 30 Apr 2010 | 1,334 | 104,995 | - | - | ISO | ||
| Chris J. Stern | Director, CEO | 30 Apr 2010 | 12,543 | 31,425 | - | - | Common Stock | ||
| Chris J. Stern | Director, CEO | 30 Apr 2010 | 587 | 31,425 | - | - | Common Stock | ||
| Chris J. Stern | Director, CEO | 30 Apr 2010 | 529 | 31,425 | - | - | Common Shares | ||
| Chris J. Stern | Director, CEO | 30 Apr 2010 | 570 | 31,425 | - | - | Common Stock | ||
| Michael B. Jebsen | CFO | 30 Apr 2010 | 667 | 9,336 | - | - | ISO | ||
| Michael B. Jebsen | CFO | 30 Apr 2010 | 667 | 9,336 | - | - | ISO | ||
| Michael B. Jebsen | CFO | 30 Apr 2010 | 667 | 9,336 | - | - | ISO |